ArticleBMC emergency medicine2025
Prognostic performance of the temperature- and age-modified shock index for children with sepsis and septic shock: a retrospective cohort study.
Article in BMC emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPediatric septic shock is associated with high mortality and morbidity rates. Lactate levels are monitored to determine the quality of sepsis treatment; however, some rural hospitals have restricted access to lactate measurements because of limited resources. This study evaluated the prognostic performance of the temperature- and age-modified shock index (TAMSI) for sepsis and septic shock in children and its ability to predict morbidity and mortality.
methodsData on children with sepsis or septic shock (age 1 month–15 years) who were admitted to the Songklanagarind Hospital pediatric intensive care unit between January 2017 and May 2022 were retrospectively reviewed. Vital signs were collected at 0, 1, 6, 12, and 24 h (t0, t1, t6, t12, t24, respectively) after sepsis diagnosis. The TAMSI cutoff scores according to age groups were referenced from the Pediatric Advanced Life Support (PALS) guidelines.
resultsThe final analysis included 300 children (171 [57%] male children) with a mean age of 73.9 months (standard deviation [SD], 63.5 months); 192 (67%) of these children were immunocompromised. The median pediatric risk of mortality score was 6 (interquartile range, 3–10). Eighty-two (27.3%) deaths occurred. The TAMSI areas under the receiver-operating characteristic curve at 0, 1, 6, 12, and 24 h for predicting mortality were 0.55, 0.58, 0.62, 0.66, and 0.67, respectively. In the multivariable logistic regression analysis, an abnormal TAMSI at t6 was significantly associated with hospital mortality (abnormal TAMSI at t0 and abnormal TAMSI at t6: adjusted odds ratio [aOR], 2.95; 95% confidence interval [CI], 1.44–6.13; P = 0.003; normal TAMSI at t0 and abnormal TAMSI at t6: aOR, 4.61; 95% CI, 1.48–14.63; P = 0.008).
conclusionsBased on the PALS guidelines, an abnormal TAMSI at 6 h after sepsis was significantly associated with mortality. The TAMSI can be a useful noninvasive monitoring tool for pediatric sepsis or septic shock at resource-limited hospitals. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.